These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18201677)

  • 1. Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren CE; Gordeuk VR; Chen WP; Barton JC; Acton RT; Speechley M; Castro O; Adams PC; Snively BM; Harris EL; Reboussin DM; McLachlan GJ; Bean R;
    Transl Res; 2008 Feb; 151(2):97-109. PubMed ID: 18201677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivariate mixture models for the joint distribution of repeated serum ferritin and transferrin saturation measured 12 years apart in a cohort of healthy middle-aged Australians.
    McLaren CE; Chen WP; Bertalli NA; Delatycki MB; Giles GG; English DR; Hopper JL; Allen KJ; Gurrin LC
    PLoS One; 2019; 14(3):e0214196. PubMed ID: 30913256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Acton RT; Lovato L; Speechley MR; McLaren CE; Harris EL; Reboussin DM; Adams PC; Dawkins FW; Gordeuk VR; Walker AP;
    Clin Genet; 2006 Jan; 69(1):48-57. PubMed ID: 16451136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2017; 16(5):802-811. PubMed ID: 28809726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
    McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM
    Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
    Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.
    Wang X; Leiendecker-Foster C; Acton RT; Barton JC; McLaren CE; McLaren GD; Gordeuk VR; Eckfeldt JH
    Blood Cells Mol Dis; 2009; 42(2):150-4. PubMed ID: 19176287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African Americans at risk for increased iron stores or liver disease.
    Dawkins FW; Gordeuk VR; Snively BM; Lovato L; Barton JC; Acton RT; McLaren GD; Leiendecker-Foster C; McLaren CE; Adams PC; Speechley M; Harris EL; Jackson S; Thomson EJ
    Am J Med; 2007 Aug; 120(8):734.e1-9. PubMed ID: 17679134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Acton RT; Dawkins FW; Adams PC; Lovato L; Leiendecker-Foster C; McLaren CE; Reboussin DM; Speechley MR; Gordeuk VR; McLaren GD; Sholinsky P; Harris EL
    Genet Test; 2005; 9(3):231-41. PubMed ID: 16225403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A; Speechley M; Adams PC
    Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver diseases in the hemochromatosis and iron overload screening study.
    Adams PC; Passmore L; Chakrabarti S; Reboussin DM; Acton RT; Barton JC; McLaren GD; Eckfeldt JH; Dawkins FW; Gordeuk VR; Harris EL; Leiendecker-Foster C; Gossman E; Sholinsky P;
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):918-23; quiz 807. PubMed ID: 16797244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    Acton RT; Barton JC; Snively BM; McLaren CE; Adams PC; Harris EL; Speechley MR; McLaren GD; Dawkins FW; Leiendecker-Foster C; Holup JL; Balasubramanyam A;
    Ethn Dis; 2006; 16(4):815-21. PubMed ID: 17061732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin and transferrin saturation in Asians and Pacific Islanders.
    Harris EL; McLaren CE; Reboussin DM; Gordeuk VR; Barton JC; Acton RT; McLaren GD; Vogt TM; Snively BM; Leiendecker-Foster C; Holup JL; Passmore LV; Eckfeldt JH; Lin E; Adams PC
    Arch Intern Med; 2007 Apr; 167(7):722-6. PubMed ID: 17420432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    Rivers CA; Barton JC; Gordeuk VR; Acton RT; Speechley MR; Snively BM; Leiendecker-Foster C; Press RD; Adams PC; McLaren GD; Dawkins FW; McLaren CE; Reboussin DM
    Blood Cells Mol Dis; 2007; 38(3):247-52. PubMed ID: 17276706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.